Precision Medicine and Immunotherapy Have Arrived for Cholangiocarcinoma: An Overview of Recent Approvals and Ongoing Clinical Trials

JCO Precis Oncol. 2023 Apr:7:e2200573. doi: 10.1200/PO.22.00573.
No abstract available

Publication types

  • Review
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bile Duct Neoplasms* / drug therapy
  • Bile Ducts, Intrahepatic
  • Cholangiocarcinoma* / drug therapy
  • Humans
  • Immunotherapy
  • Precision Medicine